Sign In
Buy BNR
$7.56
-0.170 (-2.20%)
At Close: Jun 23, 2026
Burning Rock Biotech Earnings Calls
Mar 31, 2026
-$0.200 (91.26%)
| Release date | Jun 09, 2026 |
| EPS estimate | -$2.29 |
| EPS actual | -$0.200 |
| EPS Surprise | 91.26% |
| Revenue estimate | 19.207M |
| Revenue actual | 15.684M |
| Revenue Surprise | -18.34% |
Dec 31, 2025
-$0.210 (84.97%)
| Release date | Mar 12, 2026 |
| EPS estimate | -$1.40 |
| EPS actual | -$0.210 |
| EPS Surprise | 84.97% |
| Revenue estimate | - |
| Revenue actual | 18.058M |
Sep 30, 2025
| Release date | Nov 20, 2025 |
| EPS estimate | - |
| EPS actual | -$0.260 |
| Revenue estimate | - |
| Revenue actual | 18.486M |
Jun 30, 2025
| Release date | Sep 08, 2025 |
| EPS estimate | - |
| EPS actual | -$0.150 |
| Revenue estimate | - |
| Revenue actual | 20.716M |
Last 4 Quarters for Burning Rock Biotech
Below you can see how BNR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jun 30, 2025
| Release date | Sep 08, 2025 |
| Price on release | $9.06 |
| EPS estimate | - |
| EPS actual | -$0.150 |
| Date | Price |
|---|---|
| Sep 02, 2025 | $7.84 |
| Sep 03, 2025 | $7.95 |
| Sep 04, 2025 | $8.45 |
| Sep 05, 2025 | $8.30 |
| Sep 08, 2025 | $9.06 |
| Sep 09, 2025 | $9.48 |
| Sep 10, 2025 | $8.87 |
| Sep 11, 2025 | $8.81 |
| Sep 12, 2025 | $8.30 |
| 4 days before | 15.56% |
| 4 days after | -8.39% |
| On release day | 4.64% |
| Change in period | 5.87% |
Sep 30, 2025
| Release date | Nov 20, 2025 |
| Price on release | $15.02 |
| EPS estimate | - |
| EPS actual | -$0.260 |
| Date | Price |
|---|---|
| Nov 14, 2025 | $11.51 |
| Nov 17, 2025 | $15.28 |
| Nov 18, 2025 | $14.31 |
| Nov 19, 2025 | $16.03 |
| Nov 20, 2025 | $15.02 |
| Nov 21, 2025 | $14.25 |
| Nov 24, 2025 | $16.60 |
| Nov 25, 2025 | $19.45 |
| Nov 26, 2025 | $21.34 |
| 4 days before | 30.50% |
| 4 days after | 42.08% |
| On release day | -5.13% |
| Change in period | 85.40% |
Dec 31, 2025
Beat
| Release date | Mar 12, 2026 |
| Price on release | $22.85 |
| EPS estimate | -$1.40 |
| EPS actual | -$0.210 |
| EPS surprise | 84.97% |
| Date | Price |
|---|---|
| Mar 06, 2026 | $22.25 |
| Mar 09, 2026 | $22.48 |
| Mar 10, 2026 | $23.47 |
| Mar 11, 2026 | $23.46 |
| Mar 12, 2026 | $22.85 |
| Mar 13, 2026 | $16.01 |
| Mar 16, 2026 | $16.99 |
| Mar 17, 2026 | $18.55 |
| Mar 18, 2026 | $18.62 |
| 4 days before | 2.70% |
| 4 days after | -18.51% |
| On release day | -29.93% |
| Change in period | -16.31% |
Mar 31, 2026
Beat
| Release date | Jun 09, 2026 |
| Price on release | $8.18 |
| EPS estimate | -$2.29 |
| EPS actual | -$0.200 |
| EPS surprise | 91.26% |
| Date | Price |
|---|---|
| Jun 03, 2026 | $8.69 |
| Jun 04, 2026 | $9.16 |
| Jun 05, 2026 | $9.21 |
| Jun 08, 2026 | $9.07 |
| Jun 09, 2026 | $8.18 |
| Jun 10, 2026 | $8.33 |
| Jun 11, 2026 | $8.83 |
| Jun 12, 2026 | $8.59 |
| Jun 15, 2026 | $8.76 |
| 4 days before | -5.87% |
| 4 days after | 7.09% |
| On release day | 1.83% |
| Change in period | 0.81% |
Burning Rock Biotech Earnings History
Earnings Calendar
FAQ
When is the earnings report for BNR?
Burning Rock Biotech Limited (BNR) has scheduled its earnings report for Sep 02, 2026 before the markets open.
What is the BNR price-to-earnings (P/E) ratio?
BNR P/E ratio as of Jun 23, 2026 (TTM) is -0.91.
What is the BNR EPS forecast?
The forecasted EPS (Earnings Per Share) for Burning Rock Biotech Limited (BNR) for the first fiscal quarter 2026 is -$2.31.
What are Burning Rock Biotech Limited's retained earnings?
On its balance sheet, Burning Rock Biotech Limited reported retained earnings of $15.68 million for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
